A Review of Breast Cancer Surgeries in a Sub-urban Nigerian Tertiary Hospital and the Limitations of Breast-Conserving Surgery

Overview

Journal Breast Cancer (Auckl)

Publisher Sage Publications

Date 2025 Mar 13

PMID 40078465

Authors

Esteem Tagar

James Kpolugbo

Andrew A Okomayin

Afokeoghene G Tagar

Affiliations

Soon will be listed here.

Abstract

Background: The surgical management of breast cancer involves either modified radical mastectomy or a conservative approach. Breast-conserving surgery is the preferred surgical treatment for early breast cancer in developed countries, while mastectomy is still more favoured by most centres in developing countries.

Objectives: To report some quality data on breast cancer surgeries from a sub-urban tertiary hospital in Nigeria.

Design: Retrospective analysis.

Methods: We retrospectively reviewed all breast cancer surgeries performed between January 2018 and December 2022 at the Irrua Specialist Teaching Hospital.

Results: A total of 105 female patients underwent breast cancer surgery. Their ages ranged between 27 and 85 years, with a mean of 48.8 years (SD = 12.2). The mean duration of symptoms before presentation was 12.3 ± 17.8 months (1-120 months), with 15.2% presenting with stage I and II disease and 84.7% presenting with stage III and IV disease. Invasive carcinoma NST was the most common histological type in 78 (74.3%) patients. The cancers were predominantly high grade (42.3%) and triple negative (41.5%). Only 9.5% of the patients had breast-conserving surgery, the others had mastectomy. Sixty-three patients (60%) received neoadjuvant chemotherapy while only 25.7% of patients had documented evidence of the completion of adjuvant radiotherapy.

Conclusion: The rate of breast-conserving surgery in this study was extremely low. This could be attributed to the advanced stage at presentation, predominance of aggressive tumours, limited access to radiation therapy, status of the medical system, and patient preferences.

References

Karadeniz Cakmak G, Emiroglu S, Sezer A, Canturk N, Yeniay L, Kuru B . Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery. JCO Glob Oncol. 2020; 6:285-292. PMC: 7051798. DOI: 10.1200/JGO.19.00275. View

Wong W, Mosiun J, Hidayati Z, Balkis R, Sharif S, Lee D . Low Breast Conserving Surgery (BCS) rates in public hospitals in Malaysia: The effect of stage and ethnicity. Breast. 2019; 46:136-143. DOI: 10.1016/j.breast.2019.05.016. View

Kaplan H, Malmgren J . Impact of triple negative phenotype on breast cancer prognosis. Breast J. 2008; 14(5):456-63. DOI: 10.1111/j.1524-4741.2008.00622.x. View

van Maaren M, de Munck L, de Bock G, Jobsen J, van Dalen T, Linn S . 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016; 17(8):1158-1170. DOI: 10.1016/S1470-2045(16)30067-5. View

Ali-Gombe M, Mustapha M, Folasire A, Ntekim A, Campbell O . Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria. Ecancermedicalscience. 2021; 15:1192. PMC: 8043689. DOI: 10.3332/ecancer.2021.1192. View

Mamounas E . NSABP breast cancer clinical trials: recent results and future directions. Clin Med Res. 2005; 1(4):309-26. PMC: 1069061. DOI: 10.3121/cmr.1.4.309. View

Song Y, Huang Z, Fang H, Tang Y, Jing H, Song Y . Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy. Front Oncol. 2023; 13:1178230. PMC: 10368492. DOI: 10.3389/fonc.2023.1178230. View

Gakwaya A, Kigula-Mugambe J, Kavuma A, Luwaga A, Fualal J, Jombwe J . Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer. 2008; 99(1):63-7. PMC: 2453032. DOI: 10.1038/sj.bjc.6604435. View

Anderson B, Yip C, Smith R, Shyyan R, Sener S, Eniu A . Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer. 2008; 113(8 Suppl):2221-43. DOI: 10.1002/cncr.23844. View

10.

Agarwal G, Pradeep P, Aggarwal V, Yip C, Cheung P . Spectrum of breast cancer in Asian women. World J Surg. 2007; 31(5):1031-40. DOI: 10.1007/s00268-005-0585-9. View

11.

Okebukola P, Brieger W . Providing Universal Health Insurance Coverage in Nigeria. Int Q Community Health Educ. 2016; 36(4):241-246. DOI: 10.1177/0272684X16657451. View

12.

Anyanwu S, Egwuonwu O, Ihekwoaba E . Acceptance and adherence to treatment among breast cancer patients in Eastern Nigeria. Breast. 2011; 20 Suppl 2:S51-3. DOI: 10.1016/j.breast.2011.01.009. View

13.

Ogundiran T, Ayandipo O, Ademola A, Adebamowo C . Mastectomy for management of breast cancer in Ibadan, Nigeria. BMC Surg. 2013; 13:59. PMC: 3878251. DOI: 10.1186/1471-2482-13-59. View

14.

Olasehinde O, Alatise O, Arowolo O, Mango V, Olajide O, Omisore A . Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities. Eur J Cancer Care (Engl). 2019; 28(2):e12986. PMC: 6430195. DOI: 10.1111/ecc.12986. View

15.

Goldhirsch A, Glick J, Gelber R, Coates A, Thurlimann B, Senn H . Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005; 16(10):1569-83. DOI: 10.1093/annonc/mdi326. View

16.

Bhikoo R, Srinivasa S, Yu T, Moss D, Hill A . Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South america. Cancers (Basel). 2013; 3(2):2358-81. PMC: 3757422. DOI: 10.3390/cancers3022358. View

17.

Morrow M . Personalizing extent of breast cancer surgery according to molecular subtypes. Breast. 2013; 22 Suppl 2:S106-9. DOI: 10.1016/j.breast.2013.07.020. View

18.

Mody G, Nduaguba A, Ntirenganya F, Riviello R . Characteristics and presentation of patients with breast cancer in Rwanda. Am J Surg. 2013; 205(4):409-13. DOI: 10.1016/j.amjsurg.2013.01.002. View

19.

Garcia-Etienne C, Tomatis M, Heil J, Friedrichs K, Kreienberg R, Denk A . Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. Eur J Cancer. 2012; 48(13):1947-56. DOI: 10.1016/j.ejca.2012.03.008. View

20.

Olasehinde O, Alatise O, Omisore A, Wuraola F, Odujoko O, Romanoff A . Contemporary management of breast cancer in Nigeria: Insights from an institutional database. Int J Cancer. 2021; 148(12):2906-2914. PMC: 8394611. DOI: 10.1002/ijc.33484. View